Page last updated: 2024-09-04

levofloxacin and Latent Tuberculosis

levofloxacin has been researched along with Latent Tuberculosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Behr, MA; Benedetti, A; Britton, WJ; Dowdy, DW; Fox, GJ; Graham, SM; Marais, BJ; Marks, GB; Mason, P; Menzies, D; Nguyen, BH; Nguyen, CB; Nguyen, TA; Nguyen, VN; Tran, PT; Velen, K1
Ader, F; Collardeau-Frachon, S; Gillet, Y; Huguet, A; Ohlmann, C1
Adler-Shohet, FC; Carson, M; Girma, H; Low, J; Singh, J1
Ader, F; Bouaziz, A; Catho, G; Dumitriescu, O; Pedone, C; Perpoint, T; Reix, P; Ronnaux-Baron, AS; Sénéchal, A; Valour, F1
Bamrah Morris, S; Brostrom, R; Chorba, T; Daley, CL; Fred, D; Gonzalez, D; Jereb, JA; Loeffler, AM; Martin, F; Mase, SR; Menon, LR; Peloquin, CA1

Reviews

1 review(s) available for levofloxacin and Latent Tuberculosis

ArticleYear
[Children exposed to multidrug-resistant tuberculosis: How should we manage? Analysis of 46 child contacts and review of the literature].
    Revue de pneumologie clinique, 2015, Volume: 71, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Female; France; Humans; Infant; Latent Tuberculosis; Levofloxacin; Lost to Follow-Up; Male; Tuberculosis, Multidrug-Resistant

2015

Trials

1 trial(s) available for levofloxacin and Latent Tuberculosis

ArticleYear
Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial.
    BMJ open, 2020, 01-02, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Latent Tuberculosis; Levofloxacin; Male; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vietnam; Young Adult

2020

Other Studies

3 other study(ies) available for levofloxacin and Latent Tuberculosis

ArticleYear
Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin.
    The Pediatric infectious disease journal, 2019, Volume: 38, Issue:10

    Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Humans; Latent Tuberculosis; Levofloxacin; Male; Massive Hepatic Necrosis; Pyrazinamide; Tuberculosis, Multidrug-Resistant

2019
Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis.
    The Pediatric infectious disease journal, 2014, Volume: 33, Issue:6

    Topics: Adolescent; Antibiotic Prophylaxis; Antitubercular Agents; Child; Contact Tracing; Humans; Latent Tuberculosis; Levofloxacin; Pyrazinamide; Retrospective Studies; Tuberculosis, Multidrug-Resistant

2014
Pharmacokinetics and Dosing of Levofloxacin in Children Treated for Active or Latent Multidrug-resistant Tuberculosis, Federated States of Micronesia and Republic of the Marshall Islands.
    The Pediatric infectious disease journal, 2016, Volume: 35, Issue:4

    Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Latent Tuberculosis; Levofloxacin; Male; Microbial Sensitivity Tests; Micronesia; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2016